Chu Chieh Hsia
Affiliation: Food and Drug Administration
- Quantification of hepatitis B virus genomes and infectivity in human serum samplesChu Chieh Hsia
Division of Emerging and Transfusion Transmitted Diseases, CBER, FDA, Bethesda, Maryland, USA
Transfusion 46:1829-35. 2006....
- Microarray multiplex assay for the simultaneous detection and discrimination of hepatitis B, hepatitis C, and human immunodeficiency type-1 viruses in human blood samplesChu Chieh Hsia
Division of Emerging and Transfusion Transmitted Diseases, Center for Biologics Evaluation and Review, Food and Drug Administration, Bethesda, MD 20892, USA
Biochem Biophys Res Commun 356:1017-23. 2007..Our data represent a proof-of-concept for the possible use of highly sensitive multiplex microarray assay to screen and confirm the presence of these viruses in blood donors and patients...
- Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infectionRobin Biswas
Food and Drug Administration, Center for Biologics Evaluation and Research, Rockville, Maryland, USA
Transfusion 43:788-98. 2003..Single-sample NAT would increase yield by 13 to 15 units per 107 donations over pooled-sample NAT and newer HBsAg assays and by 35 to 50 units per 107 donations over currently licensed HBsAg assays...
- Truncated hepatitis C virus core protein encoded in hepatocellular carcinomasRin Yamaguchi
Division of Emerging and Transfusion Transmitted Diseases, Food and Drug Administration, Bethesda, MD 20852, USA
Int J Mol Med 14:1097-100. 2004....